Clinical Trial Update: Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab

View source ↗

Summary

This trial update reports detection of neutralizing antibodies in patients treated with bevacizumab or ranibizumab for age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Bevacizumab (bevacizumab)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Macular Degeneration | Status: COMPLETED